IRS1 and prostate cancer: miR-21-5p inhibition downregulates SREBP1 expression by suppressing insulin receptor substrate 1 (IRS1)-mediated transcription and inducing senescence in prostate cancer cells, which is reversed by miR-21-5p overexpression [113].